STOCK TITAN

[8-K] Prestige Consumer Healthcare Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

MUFG’s June-quarter (FY25 Q1) results under J-GAAP show modest earnings resilience amid softer revenues. Ordinary income fell 7.7% YoY to ¥3.25 tn, driven by a ¥330 bn drop in interest income and weaker trading gains, while ordinary profit slipped 3.4% to ¥708.5 bn. Profit attributable to owners declined just 1.8% to ¥546.1 bn, keeping basic EPS nearly flat at ¥47.55.

Asset quality and funding trends improved. Total credit costs were ¥46.9 bn (vs. ¥166.8 bn loss a year ago) and the consolidated NPL ratio narrowed to 1.05% (1.11% Mar-25). Domestic loan-deposit spread widened to 0.89 ppt (0.80 ppt), aided by higher loan yields and deposit repricing. Total assets decreased 2.9% QoQ to ¥401 tn, but the equity ratio stayed at 5.0%.

Capital return outlook strengthened. Management maintained its FY25 profit target of ¥2.0 tn and reiterated the full-year dividend plan of ¥70 (up 9% YoY), implying a progressive payout. No changes were made to subsidiary structure, accounting policies (aside from an immaterial credit-rating model tweak) or guidance.

Overall, MUFG delivered stable bottom-line results despite revenue pressure, helped by lower credit costs, wider spreads and disciplined expenses, while signalling confidence through a higher dividend.

I risultati di MUFG per il trimestre di giugno (FY25 Q1) secondo J-GAAP mostrano una modesta resilienza degli utili nonostante ricavi più deboli. Il reddito ordinario è diminuito del 7,7% su base annua a ¥3,25 trilioni, principalmente a causa di una riduzione di ¥330 miliardi degli interessi attivi e di minori guadagni da trading, mentre il profitto ordinario è sceso del 3,4% a ¥708,5 miliardi. L'utile attribuibile ai proprietari è calato solo dell'1,8% a ¥546,1 miliardi, mantenendo l'EPS base quasi stabile a ¥47,55.

La qualità degli attivi e le tendenze di finanziamento sono migliorate. I costi totali per crediti deteriorati sono stati di ¥46,9 miliardi (contro una perdita di ¥166,8 miliardi un anno prima) e il rapporto NPL consolidato si è ridotto all'1,05% (1,11% a marzo 2025). Lo spread tra prestiti e depositi domestici si è ampliato a 0,89 punti percentuali (da 0,80), favorito da rendimenti dei prestiti più elevati e dalla rivalutazione dei depositi. Il totale degli attivi è diminuito del 2,9% su base trimestrale a ¥401 trilioni, ma il rapporto patrimoniale è rimasto al 5,0%.

Le prospettive di ritorno del capitale si sono rafforzate. La direzione ha confermato l'obiettivo di utile per l'anno fiscale 25 a ¥2,0 trilioni e ha ribadito il piano di dividendo annuale di ¥70 (in aumento del 9% su base annua), suggerendo una politica di distribuzione progressiva. Non sono state apportate modifiche alla struttura delle controllate, alle politiche contabili (tranne una modifica marginale al modello di valutazione del rating creditizio) o alle indicazioni fornite.

In generale, MUFG ha consegnato risultati stabili a livello di utile netto nonostante la pressione sui ricavi, supportata da costi per crediti più bassi, spread più ampi e spese contenute, mostrando fiducia attraverso un dividendo più elevato.

Los resultados de MUFG del trimestre de junio (FY25 Q1) bajo J-GAAP muestran una modesta resistencia en las ganancias a pesar de ingresos más débiles. Los ingresos ordinarios cayeron un 7,7% interanual hasta ¥3,25 billones, impulsados por una disminución de ¥330 mil millones en ingresos por intereses y menores ganancias comerciales, mientras que la utilidad ordinaria bajó un 3,4% a ¥708,5 mil millones. La utilidad atribuible a los propietarios disminuyó solo un 1,8% a ¥546,1 mil millones, manteniendo el BPA básico casi sin cambios en ¥47,55.

La calidad de los activos y las tendencias de financiamiento mejoraron. Los costos totales de crédito fueron ¥46,9 mil millones (frente a una pérdida de ¥166,8 mil millones hace un año) y la tasa consolidada de préstamos morosos se redujo a 1,05% (1,11% en marzo de 2025). El diferencial préstamo-depósito doméstico se amplió a 0,89 puntos porcentuales (0,80), impulsado por mayores rendimientos de préstamos y reajustes en depósitos. Los activos totales disminuyeron un 2,9% trimestralmente a ¥401 billones, pero la ratio de capital se mantuvo en 5,0%.

Se fortaleció la perspectiva de retorno de capital. La dirección mantuvo su objetivo de beneficio para FY25 en ¥2,0 billones y reiteró el plan de dividendo anual de ¥70 (un aumento del 9% interanual), lo que implica un pago progresivo. No se realizaron cambios en la estructura de subsidiarias, políticas contables (excepto un ajuste menor en el modelo de calificación crediticia) ni en la guía.

En general, MUFG entregó resultados estables en la línea de fondo a pesar de la presión en los ingresos, ayudado por menores costos de crédito, diferenciales más amplios y gastos disciplinados, mientras muestra confianza a través de un dividendo mayor.

MUFG의 6월 분기(FY25 1분기) J-GAAP 기준 실적은 수익 감소에도 불구하고 견조한 이익을 기록했습니다. 영업수익은 전년 대비 7.7% 감소한 3조 2500억 엔으로, 이자수익 3300억 엔 감소와 약화된 거래손익이 원인입니다. 영업이익은 3.4% 감소한 7085억 엔을 기록했습니다. 소유주 귀속 이익은 1.8% 감소한 5461억 엔에 그쳐, 기본 주당순이익(EPS)은 거의 변동 없이 47.55엔을 유지했습니다.

자산 건전성과 자금 조달 동향이 개선되었습니다. 총 신용비용은 469억 엔(전년 동기 1668억 엔 손실 대비)이며, 연결 부실채권 비율은 1.05%(2025년 3월 1.11%)로 축소되었습니다. 국내 대출-예금 스프레드는 0.89%포인트(0.80%포인트)로 확대되었으며, 이는 대출 수익률 상승과 예금 금리 재조정에 힘입은 결과입니다. 총자산은 전분기 대비 2.9% 감소한 401조 엔이지만, 자기자본비율은 5.0%를 유지했습니다.

자본 환원 전망이 강화되었습니다. 경영진은 FY25 이익 목표 2조 엔을 유지하고, 연간 배당금 70엔(전년 대비 9% 증가) 계획을 재확인하며 점진적 배당 정책을 시사했습니다. 자회사 구조, 회계 정책(신용 등급 모델의 미미한 조정 제외), 가이던스에는 변동이 없었습니다.

전반적으로 MUFG는 수익 압박에도 불구하고 낮은 신용비용, 확대된 스프레드, 절제된 비용 덕분에 안정적인 순이익을 기록했으며, 높은 배당을 통해 자신감을 나타냈습니다.

Les résultats du trimestre de juin de MUFG (FY25 Q1) selon les normes J-GAAP montrent une résilience modérée des bénéfices malgré des revenus plus faibles. Le revenu ordinaire a diminué de 7,7 % en glissement annuel à 3,25 trillions de yens, en raison d'une baisse de 330 milliards de yens des revenus d'intérêts et d'une diminution des gains de trading, tandis que le bénéfice ordinaire a reculé de 3,4 % à 708,5 milliards de yens. Le bénéfice attribuable aux propriétaires a chuté de seulement 1,8 % à 546,1 milliards de yens, maintenant le BPA de base quasiment stable à 47,55 yens.

La qualité des actifs et les tendances de financement se sont améliorées. Les coûts totaux de crédit se sont élevés à 46,9 milliards de yens (contre une perte de 166,8 milliards un an auparavant) et le ratio consolidé de prêts non performants s'est réduit à 1,05 % (contre 1,11 % en mars 2025). L'écart entre les prêts et les dépôts domestiques s'est élargi à 0,89 point de pourcentage (0,80), soutenu par des rendements de prêts plus élevés et une revalorisation des dépôts. Le total des actifs a diminué de 2,9 % en glissement trimestriel à 401 trillions de yens, mais le ratio de fonds propres est resté à 5,0 %.

Les perspectives de retour sur capital se sont renforcées. La direction a maintenu son objectif de bénéfice pour l'exercice 25 à 2,0 trillions de yens et a réitéré le plan de dividende annuel de 70 yens (en hausse de 9 % en glissement annuel), ce qui implique une politique de distribution progressive. Aucune modification n'a été apportée à la structure des filiales, aux politiques comptables (à l'exception d'un ajustement mineur du modèle de notation de crédit) ni aux prévisions.

Dans l'ensemble, MUFG a livré des résultats nets stables malgré la pression sur les revenus, aidé par des coûts de crédit plus faibles, des écarts plus larges et des dépenses maîtrisées, tout en affichant sa confiance par un dividende plus élevé.

Die Ergebnisse von MUFG für das Juni-Quartal (FY25 Q1) nach J-GAAP zeigen eine moderate Ertragsresilienz trotz schwächerer Umsätze. Das ordentliche Einkommen sank im Jahresvergleich um 7,7 % auf ¥3,25 Billionen, bedingt durch einen Rückgang der Zinserträge um ¥330 Milliarden und schwächere Handelsgewinne, während der ordentliche Gewinn um 3,4 % auf ¥708,5 Milliarden zurückging. Der den Eigentümern zurechenbare Gewinn sank nur um 1,8 % auf ¥546,1 Milliarden, wodurch das bereinigte Ergebnis je Aktie (EPS) nahezu unverändert bei ¥47,55 blieb.

Die Vermögensqualität und die Finanzierungstrends verbesserten sich. Die gesamten Kreditkosten betrugen ¥46,9 Milliarden (gegenüber einem Verlust von ¥166,8 Milliarden vor einem Jahr) und die konsolidierte NPL-Quote verringerte sich auf 1,05 % (1,11 % im März 2025). Die inländische Kredit-Einlagen-Spanne weitete sich auf 0,89 Prozentpunkte (0,80) aus, begünstigt durch höhere Kreditzinsen und eine Anpassung der Einlagenzinsen. Die Gesamtaktiva sanken quartalsweise um 2,9 % auf ¥401 Billionen, aber die Eigenkapitalquote blieb bei 5,0 %.

Die Kapitalrückflussaussichten wurden gestärkt. Das Management bestätigte das Gewinnziel für FY25 von ¥2,0 Billionen und bekräftigte den Dividendenplan für das Gesamtjahr von ¥70 (ein Plus von 9 % im Jahresvergleich), was auf eine progressive Ausschüttung hinweist. Es wurden keine Änderungen an der Tochtergesellschaftsstruktur, den Bilanzierungsgrundsätzen (außer einer geringfügigen Anpassung des Kredit-Rating-Modells) oder der Prognose vorgenommen.

Insgesamt lieferte MUFG trotz Umsatzdruck stabile Nettoergebnisse, unterstützt durch niedrigere Kreditkosten, breitere Spreads und disziplinierte Ausgaben, und signalisierte Vertrauen durch eine höhere Dividende.

Positive
  • Credit costs down to ¥46.9 bn from ¥166.8 bn, boosting bottom-line resilience.
  • NPL ratio improved to 1.05% (-6 bp QoQ).
  • Domestic loan-deposit spread widened 9 bp YoY, indicating pricing power.
  • Dividend forecast raised to ¥70 (+9% YoY), signalling management confidence.
Negative
  • Ordinary income declined 7.7% YoY; trading profit fell 65 bn.
  • Comprehensive income plunged 86% due to OCI losses on FX and securities.
  • Equity ratio remains low at 5.0%, reflecting high leverage.
  • Total assets contracted ¥12 tn QoQ, partly from securities run-off.

Insights

TL;DR – Earnings slightly down but credit costs and dividend policy offset headline weakness; overall neutral-to-positive.

Top-line contraction (-7.7% revenue, -65% trading profit) was largely macro-driven, yet MUFG contained the bottom-line decline to 1.8% and beat consensus on credit-cost relief. Net interest income held up reasonably, and the 9 bp spread expansion suggests rising JPY rates are feeding through. Asset quality metrics improved and the NPL ratio now sits near post-GFC lows. Equity ratio remains thin at 5%, but the bank’s Basel-III CET1 (not disclosed here) is historically far higher, easing leverage concerns. Maintaining the ¥2 tn profit target and hiking the dividend to ¥70 signals management confidence. However, comprehensive income collapsed due to FX and securities valuation, highlighting market-sensitive OCI volatility. Net unrealised bond losses also widened. Overall impact: modestly positive for long-term investors but unlikely to be a near-term catalyst.

TL;DR – Mixed quarter; credit trends good, revenue weak, shares likely range-bound.

The 3.4% dip in ordinary profit is acceptable given global rate volatility. Spread improvement is encouraging but comes off a low base; absolute ROE (10.8%) is only average among megabanks. Trading-income slump and unrealised bond losses show sensitivity to markets. Dividend increase is welcome yet uses modest cash (c. ¥800 bn). With guidance unchanged, there is little to re-rate the stock near term. Impact deemed neutral; focus shifts to September half-year when U.S. GAAP numbers arrive.

I risultati di MUFG per il trimestre di giugno (FY25 Q1) secondo J-GAAP mostrano una modesta resilienza degli utili nonostante ricavi più deboli. Il reddito ordinario è diminuito del 7,7% su base annua a ¥3,25 trilioni, principalmente a causa di una riduzione di ¥330 miliardi degli interessi attivi e di minori guadagni da trading, mentre il profitto ordinario è sceso del 3,4% a ¥708,5 miliardi. L'utile attribuibile ai proprietari è calato solo dell'1,8% a ¥546,1 miliardi, mantenendo l'EPS base quasi stabile a ¥47,55.

La qualità degli attivi e le tendenze di finanziamento sono migliorate. I costi totali per crediti deteriorati sono stati di ¥46,9 miliardi (contro una perdita di ¥166,8 miliardi un anno prima) e il rapporto NPL consolidato si è ridotto all'1,05% (1,11% a marzo 2025). Lo spread tra prestiti e depositi domestici si è ampliato a 0,89 punti percentuali (da 0,80), favorito da rendimenti dei prestiti più elevati e dalla rivalutazione dei depositi. Il totale degli attivi è diminuito del 2,9% su base trimestrale a ¥401 trilioni, ma il rapporto patrimoniale è rimasto al 5,0%.

Le prospettive di ritorno del capitale si sono rafforzate. La direzione ha confermato l'obiettivo di utile per l'anno fiscale 25 a ¥2,0 trilioni e ha ribadito il piano di dividendo annuale di ¥70 (in aumento del 9% su base annua), suggerendo una politica di distribuzione progressiva. Non sono state apportate modifiche alla struttura delle controllate, alle politiche contabili (tranne una modifica marginale al modello di valutazione del rating creditizio) o alle indicazioni fornite.

In generale, MUFG ha consegnato risultati stabili a livello di utile netto nonostante la pressione sui ricavi, supportata da costi per crediti più bassi, spread più ampi e spese contenute, mostrando fiducia attraverso un dividendo più elevato.

Los resultados de MUFG del trimestre de junio (FY25 Q1) bajo J-GAAP muestran una modesta resistencia en las ganancias a pesar de ingresos más débiles. Los ingresos ordinarios cayeron un 7,7% interanual hasta ¥3,25 billones, impulsados por una disminución de ¥330 mil millones en ingresos por intereses y menores ganancias comerciales, mientras que la utilidad ordinaria bajó un 3,4% a ¥708,5 mil millones. La utilidad atribuible a los propietarios disminuyó solo un 1,8% a ¥546,1 mil millones, manteniendo el BPA básico casi sin cambios en ¥47,55.

La calidad de los activos y las tendencias de financiamiento mejoraron. Los costos totales de crédito fueron ¥46,9 mil millones (frente a una pérdida de ¥166,8 mil millones hace un año) y la tasa consolidada de préstamos morosos se redujo a 1,05% (1,11% en marzo de 2025). El diferencial préstamo-depósito doméstico se amplió a 0,89 puntos porcentuales (0,80), impulsado por mayores rendimientos de préstamos y reajustes en depósitos. Los activos totales disminuyeron un 2,9% trimestralmente a ¥401 billones, pero la ratio de capital se mantuvo en 5,0%.

Se fortaleció la perspectiva de retorno de capital. La dirección mantuvo su objetivo de beneficio para FY25 en ¥2,0 billones y reiteró el plan de dividendo anual de ¥70 (un aumento del 9% interanual), lo que implica un pago progresivo. No se realizaron cambios en la estructura de subsidiarias, políticas contables (excepto un ajuste menor en el modelo de calificación crediticia) ni en la guía.

En general, MUFG entregó resultados estables en la línea de fondo a pesar de la presión en los ingresos, ayudado por menores costos de crédito, diferenciales más amplios y gastos disciplinados, mientras muestra confianza a través de un dividendo mayor.

MUFG의 6월 분기(FY25 1분기) J-GAAP 기준 실적은 수익 감소에도 불구하고 견조한 이익을 기록했습니다. 영업수익은 전년 대비 7.7% 감소한 3조 2500억 엔으로, 이자수익 3300억 엔 감소와 약화된 거래손익이 원인입니다. 영업이익은 3.4% 감소한 7085억 엔을 기록했습니다. 소유주 귀속 이익은 1.8% 감소한 5461억 엔에 그쳐, 기본 주당순이익(EPS)은 거의 변동 없이 47.55엔을 유지했습니다.

자산 건전성과 자금 조달 동향이 개선되었습니다. 총 신용비용은 469억 엔(전년 동기 1668억 엔 손실 대비)이며, 연결 부실채권 비율은 1.05%(2025년 3월 1.11%)로 축소되었습니다. 국내 대출-예금 스프레드는 0.89%포인트(0.80%포인트)로 확대되었으며, 이는 대출 수익률 상승과 예금 금리 재조정에 힘입은 결과입니다. 총자산은 전분기 대비 2.9% 감소한 401조 엔이지만, 자기자본비율은 5.0%를 유지했습니다.

자본 환원 전망이 강화되었습니다. 경영진은 FY25 이익 목표 2조 엔을 유지하고, 연간 배당금 70엔(전년 대비 9% 증가) 계획을 재확인하며 점진적 배당 정책을 시사했습니다. 자회사 구조, 회계 정책(신용 등급 모델의 미미한 조정 제외), 가이던스에는 변동이 없었습니다.

전반적으로 MUFG는 수익 압박에도 불구하고 낮은 신용비용, 확대된 스프레드, 절제된 비용 덕분에 안정적인 순이익을 기록했으며, 높은 배당을 통해 자신감을 나타냈습니다.

Les résultats du trimestre de juin de MUFG (FY25 Q1) selon les normes J-GAAP montrent une résilience modérée des bénéfices malgré des revenus plus faibles. Le revenu ordinaire a diminué de 7,7 % en glissement annuel à 3,25 trillions de yens, en raison d'une baisse de 330 milliards de yens des revenus d'intérêts et d'une diminution des gains de trading, tandis que le bénéfice ordinaire a reculé de 3,4 % à 708,5 milliards de yens. Le bénéfice attribuable aux propriétaires a chuté de seulement 1,8 % à 546,1 milliards de yens, maintenant le BPA de base quasiment stable à 47,55 yens.

La qualité des actifs et les tendances de financement se sont améliorées. Les coûts totaux de crédit se sont élevés à 46,9 milliards de yens (contre une perte de 166,8 milliards un an auparavant) et le ratio consolidé de prêts non performants s'est réduit à 1,05 % (contre 1,11 % en mars 2025). L'écart entre les prêts et les dépôts domestiques s'est élargi à 0,89 point de pourcentage (0,80), soutenu par des rendements de prêts plus élevés et une revalorisation des dépôts. Le total des actifs a diminué de 2,9 % en glissement trimestriel à 401 trillions de yens, mais le ratio de fonds propres est resté à 5,0 %.

Les perspectives de retour sur capital se sont renforcées. La direction a maintenu son objectif de bénéfice pour l'exercice 25 à 2,0 trillions de yens et a réitéré le plan de dividende annuel de 70 yens (en hausse de 9 % en glissement annuel), ce qui implique une politique de distribution progressive. Aucune modification n'a été apportée à la structure des filiales, aux politiques comptables (à l'exception d'un ajustement mineur du modèle de notation de crédit) ni aux prévisions.

Dans l'ensemble, MUFG a livré des résultats nets stables malgré la pression sur les revenus, aidé par des coûts de crédit plus faibles, des écarts plus larges et des dépenses maîtrisées, tout en affichant sa confiance par un dividende plus élevé.

Die Ergebnisse von MUFG für das Juni-Quartal (FY25 Q1) nach J-GAAP zeigen eine moderate Ertragsresilienz trotz schwächerer Umsätze. Das ordentliche Einkommen sank im Jahresvergleich um 7,7 % auf ¥3,25 Billionen, bedingt durch einen Rückgang der Zinserträge um ¥330 Milliarden und schwächere Handelsgewinne, während der ordentliche Gewinn um 3,4 % auf ¥708,5 Milliarden zurückging. Der den Eigentümern zurechenbare Gewinn sank nur um 1,8 % auf ¥546,1 Milliarden, wodurch das bereinigte Ergebnis je Aktie (EPS) nahezu unverändert bei ¥47,55 blieb.

Die Vermögensqualität und die Finanzierungstrends verbesserten sich. Die gesamten Kreditkosten betrugen ¥46,9 Milliarden (gegenüber einem Verlust von ¥166,8 Milliarden vor einem Jahr) und die konsolidierte NPL-Quote verringerte sich auf 1,05 % (1,11 % im März 2025). Die inländische Kredit-Einlagen-Spanne weitete sich auf 0,89 Prozentpunkte (0,80) aus, begünstigt durch höhere Kreditzinsen und eine Anpassung der Einlagenzinsen. Die Gesamtaktiva sanken quartalsweise um 2,9 % auf ¥401 Billionen, aber die Eigenkapitalquote blieb bei 5,0 %.

Die Kapitalrückflussaussichten wurden gestärkt. Das Management bestätigte das Gewinnziel für FY25 von ¥2,0 Billionen und bekräftigte den Dividendenplan für das Gesamtjahr von ¥70 (ein Plus von 9 % im Jahresvergleich), was auf eine progressive Ausschüttung hinweist. Es wurden keine Änderungen an der Tochtergesellschaftsstruktur, den Bilanzierungsgrundsätzen (außer einer geringfügigen Anpassung des Kredit-Rating-Modells) oder der Prognose vorgenommen.

Insgesamt lieferte MUFG trotz Umsatzdruck stabile Nettoergebnisse, unterstützt durch niedrigere Kreditkosten, breitere Spreads und disziplinierte Ausgaben, und signalisierte Vertrauen durch eine höhere Dividende.

0001295947false00012959472025-08-072025-08-07


 

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): August 7, 2025

 
PRESTIGE CONSUMER HEALTHCARE INC.
(Exact Name of Registrant as Specified in Charter)
 
Delaware001-3243320-1297589
(State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)

 
660 White Plains Road, Tarrytown, New York 10591
(Address of Principal Executive Offices) (Zip Code)
 
(914) 524-6800
(Registrant's telephone number, including area code)

(Former Name or Former Address, if Changed Since Last Report.)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, par value $0.01 per sharePBHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 1.01 Entry into a Material Definitive Agreement.

On August 4, 2025, Medtech Pharma Holdings Limited (“Purchaser”), an Ontario corporation and a wholly-owned indirect subsidiary of Prestige Consumer Healthcare Inc. (the “Company”), entered into a definitive agreement (the “Share Purchase Agreement”) with ANJAC SAS, a French company (“ANJAC”). The Share Purchase Agreement provides that, upon the terms and subject to the conditions set forth therein, Purchaser will acquire all of the shares of Pillar5 Pharma Inc., a Canadian company that is a leading sterile ophthalmic manufacturer and current Clear Eyes® supplier (“Pillar5”), from ANJAC for CAD 150 million in cash, subject to certain adjustments, including indebtedness, as provided in the Share Purchase Agreement (the “Transaction”).

The Company expects the Transaction to close in the third quarter of Fiscal 2026.

The closing of the Transaction is subject to the satisfaction or waiver of certain conditions relating to the operational and regulatory state of the Pillar5 factory and other customary conditions to closing.

The Share Purchase Agreement contains customary representations, warranties, and covenants of both Purchaser and ANJAC, as well as indemnification provisions that are subject to specified limitations. Purchaser has obtained representation and warranty insurance, which serves as Purchaser’s sole recourse for losses related to breaches of ANJAC’s representations and warranties, other than in the case of fraud. Subject to certain exceptions and limitations, Purchaser and ANJAC have agreed to indemnify each other for breaches of post-closing covenants, fraud and other specified matters contained in the Share Purchase Agreement.

The Share Purchase Agreement also contains certain customary termination rights for each of Purchaser and ANJAC. The Share Purchase Agreement may be terminated by either Purchaser or ANJAC if the closing of the Transaction has not occurred prior to December 31, 2025, subject to certain exceptions specified in the Share Purchase Agreement. The Share Purchase Agreement may also be terminated by either Purchaser or ANJAC if the other party is in breach of the Share Purchase Agreement, such that it has not met its closing conditions and has not or is not able to cure such breach.

The foregoing description of the terms of the Share Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Share Purchase Agreement. The Company expects to file a copy of the Share Purchase Agreement as an exhibit to its Quarterly Report on Form 10-Q for the quarter ended September 30, 2025.

The Share Purchase Agreement contains various representations and warranties made by the parties solely for purposes of the Share Purchase Agreement and as of specific dates set forth therein, which were the product of negotiations, and may be subject to important qualifications and limitations included in confidential disclosure schedules of the Share Purchase Agreement. Certain representations and warranties in the Share Purchase Agreement were used for the purpose of allocating risk between the parties, rather than establishing matters of fact. Furthermore, the representations and warranties may be subject to standards of materiality applicable to the parties that may be different from those applicable to the Company’s stockholders. Additionally, information concerning the subject matter of such representations and warranties may change after the date of the Share Purchase Agreement, which subsequent information may or may not be fully reflected in the Company’s public disclosures. Accordingly, such representations and warranties in the Share Purchase Agreement may not constitute the actual state of facts about ANJAC, the Company, or Purchaser. Stockholders of the Company are not third-party beneficiaries under the Share Purchase Agreement and should not rely on the representations, warranties, and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of ANJAC (or any of its subsidiaries), the Company, or Purchaser or any of their respective subsidiaries or affiliates.

Item 2.02 Results of Operations and Financial Condition.
 
On August 7, 2025, the Company announced financial results for the fiscal quarter ended June 30, 2025. A copy of the press release announcing the Company's earnings results for the fiscal quarter ended June 30, 2025 is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 7.01 Regulation FD Disclosure.

On August 7, 2025, representatives of the Company began making presentations to investors regarding the Company's financial results for the quarter ended June 30, 2025 using slides attached to this Current Report on Form 8-K as Exhibit 99.2



(the “Investor Presentation”) and incorporated herein by reference.  The Company expects to use the Investor Presentation, in whole or in part, and possibly with modifications, in connection with presentations to investors, analysts and others during the fiscal year ended March 31, 2026.
 
By furnishing the information contained in this Item 7.01, the Company makes no admission as to the materiality of any information that is required to be disclosed solely by reason of Regulation FD.
 
The information contained in the Investor Presentation is summary information that is intended to be considered in the context of the Company's Securities and Exchange Commission (“SEC”) filings and other public announcements that the Company may make, by press release or otherwise, from time to time.  The Company undertakes no duty or obligation to publicly update or revise the information contained in this report, although it may do so from time to time as its management believes is warranted.  Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosure.

The information presented in Items 2.02 and 7.01 of this Current Report on Form 8-K and Exhibits 99.1 and 99.2 shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered “filed” under the Exchange Act or specifically incorporates it by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01 Financial Statements and Exhibits.
 
(d)    Exhibits.
 
See Exhibit Index immediately following the signature page.

 




SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated: August 7, 2025PRESTIGE CONSUMER HEALTHCARE INC. 
    
 By:/s/ Christine Sacco 
  Christine Sacco 
  Chief Financial Officer & Chief Operating Officer 




 
EXHIBIT INDEX
 
ExhibitDescription
99.1
Press Release dated August 7, 2025 announcing the Company's financial results for the fiscal quarter ended June 30, 2025 (furnished only).
99.2
Investor Presentation in use beginning August 7, 2025 (furnished only).
104Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).

FAQ

How much did Mitsubishi UFJ (MUFG) earn in Q1 FY25?

Profit attributable to owners was ¥546.1 bn, down 1.8% year-on-year.

What is MUFG’s FY25 dividend outlook?

The bank targets a ¥70 per share full-year dividend (two ¥35 instalments), up from ¥64 last year.

Did asset quality improve for MUFG?

Yes. The NPL ratio fell to 1.05% and total credit costs dropped by ¥120 bn YoY.

What revenue trends affected MUFG’s quarter?

Ordinary income dropped 7.7% mainly due to lower interest income and trading gains.

Is MUFG maintaining its full-year earnings target?

Yes. Management reiterated a ¥2.0 tn profit target for the year ending March 2026.
Prestige Consmr Healthcare Inc

NYSE:PBH

PBH Rankings

PBH Latest News

PBH Latest SEC Filings

PBH Stock Data

3.65B
48.61M
1.23%
108.53%
3.08%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
TARRYTOWN